CITANEST PLAIN DENTAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Citanest Plain Dental, and what generic alternatives are available?
Citanest Plain Dental is a drug marketed by Dentsply Pharm and is included in one NDA.
The generic ingredient in CITANEST PLAIN DENTAL is prilocaine hydrochloride. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prilocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Citanest Plain Dental
A generic version of CITANEST PLAIN DENTAL was approved as prilocaine hydrochloride by SEPTODONT INC on September 29th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CITANEST PLAIN DENTAL?
- What are the global sales for CITANEST PLAIN DENTAL?
- What is Average Wholesale Price for CITANEST PLAIN DENTAL?
Summary for CITANEST PLAIN DENTAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CITANEST PLAIN DENTAL at DailyMed |
US Patents and Regulatory Information for CITANEST PLAIN DENTAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dentsply Pharm | CITANEST PLAIN DENTAL | prilocaine hydrochloride | INJECTABLE;INJECTION | 021382-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
